Milk Thistle: What Actually Works (And What Doesn't) According to the Trials

Milk thistle is one of the oldest liver-support herbs in traditional use. The modern trial data is more specific, and more interesting, than the generic detox claim usually attached to it.

This formula pairs milk thistle (350mg equivalent) with beta-glucans and a prebiotic-style fibre stack. That combination isn't random, it mirrors an actual tested formulation in the clinical literature, which makes this one of the more evidence-grounded ingredient pairings on the label.

What the research actually shows

Milk thistle's active compound, silymarin, doesn't perform well as a solo act in isolation. A 2022 systematic review and meta-analysis by Mohtashaminia et al., published in Clinical Nutrition ESPEN, pooled 5 trials (549 participants) testing berberine combined with silymarin against liver enzymes ALT and AST. The result: no statistically significant change in either marker. This is worth stating plainly rather than glossing over, silymarin alone, or in this particular combination, did not measurably improve standard liver enzyme markers in this pooled analysis.

But a different combination tells a more favourable story. A 2023 double-blind randomised controlled trial by Nehmi-Filho et al., published in Frontiers in Endocrinology, tested a nutraceutical supplement combining yeast beta-glucan, prebiotics, minerals, and silymarin, structurally very similar to what's in this product, in sedentary adults with overweight or obesity, with no dietary intervention during the study. Over 180 days, both waist circumference measurements improved, and the AST/ALT ratio, a recognised biomarker for non-alcoholic fatty liver disease, improved alongside reductions in cortisol and thyroid-stimulating hormone. This is a meaningfully different result from the berberine-silymarin trial, and the difference appears to be the multi-ingredient formulation: beta-glucan and prebiotic fibre paired with silymarin outperformed silymarin in a narrower combination.

What this means for you

The honest read: don't take milk thistle as an isolated liver-cleansing ingredient and expect it to move standard liver enzyme markers on its own, the pooled trial evidence doesn't support that specific claim. What the evidence does support is a broader formulation approach, silymarin alongside beta-glucan and fibre, exactly the structure in this product, showing real improvements in metabolic markers relevant to liver health, particularly the AST/ALT ratio used clinically to flag fatty liver risk.

This distinction matters because it's a useful lesson in reading supplement labels generally: an ingredient with weak solo evidence can still be part of a formulation with genuine trial support, if the combination itself has been tested, which is different from assuming any single liver support herb works in isolation.

Practically, this supports the case for consistent daily use rather than an occasional cleanse mentality, the positive trial ran 180 days, with measurable change building over that period, not from a single dose or short course.

The biotype angle

Endomorphs carrying higher body fat, particularly visceral fat, are the biotype most directly relevant to the fatty liver risk marker this combination targets, the AST/ALT ratio improvement in the trial was specifically measured in an overweight/obese population.

Mesomorphs and ectomorphs without elevated metabolic risk markers are less likely to see a measurable liver-marker benefit from this component, though the beta-glucan and fibre components still contribute to the broader gut and metabolic support covered elsewhere in this formula.

Anyone with existing liver conditions should treat this as general wellness support, not medical treatment, diagnosed liver disease needs medical management, and this ingredient combination's evidence is in a healthy-but-overweight population, not a clinical liver disease population.

Download the free Biotype Guide at milenium.com.au
→ milenium.com.au

References:
1. Mohtashaminia F et al. Effects berberine-silymarin on liver enzymes: A systematic review and meta-analysis. Clinical Nutrition ESPEN, 2022. DOI: 10.1016/j.clnesp.2022.01.037
2. Nehmi-Filho V et al. Novel nutraceutical supplements with yeast beta-glucan, prebiotics, minerals, and silymarin ameliorate obesity-related metabolic and clinical parameters. Frontiers in Endocrinology, 2023. DOI: 10.3389/fendo.2022.1089938